Cyril H. Benes
Harvard University(US)Massachusetts General Hospital(US)Novartis (China)(CN)Novartis (United States)(US)Center for Cancer Research(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, RNA modifications and cancer, Protein Degradation and Inhibitors, Cancer therapeutics and mechanisms, Lung Cancer Research Studies
Most-Cited Works
- → Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells(2012)4,219 cited
- → Systematic identification of genomic markers of drug sensitivity in cancer cells(2012)2,534 cited
- → A Landscape of Pharmacogenomic Interactions in Cancer(2016)2,211 cited
- → Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers(2012)1,320 cited
- → Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK -Rearranged Lung Cancer(2016)1,131 cited
- → Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility(2014)903 cited